Kinetensin

CAS No. 103131-69-7

Kinetensin( Kinetensin (human) )

Catalog No. M29815 CAS No. 103131-69-7

Kinetensin is a neurotensin-like peptide.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 133 Get Quote
10MG 214 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote

Biological Information

  • Product Name
    Kinetensin
  • Note
    Research use only, not for human use.
  • Brief Description
    Kinetensin is a neurotensin-like peptide.
  • Description
    Kinetensin is a neurotensin-like peptide.(In Vitro):The peptide kinetensin isolated from pepsin-treated human plasma induces a dose-dependent release of histamine when exposed to rat peritoneal mast cells. The threshold concentration is around 1 μM, the ED50 is 10 μM, and the optimal concentration of between 100 to 1000 μM released 80% of the total histamine. Kinetensin is 10 to 100 times less potent than neurotensin and equipotent with the opioid peptide dynorphin. The histamine release is clearly temperature-dependent, with no release occurring at 0 or 45 °C and with an optimum around 37 °C. The histamine release is significantly reduced in the absence of extracellular calcium.(In Vivo):Kinetensin also induces a dose-dependent increase in vascular permeability when injected intradermally into rats.
  • In Vitro
    The peptide kinetensin isolated from pepsin-treated human plasma induces a dose-dependent release of histamine when exposed to rat peritoneal mast cells. The threshold concentration is around 1 μM, the ED50 is 10 μM, and the optimal concentration of between 100 to 1000 μM released 80% of the total histamine. Kinetensin is 10 to 100 times less potent than neurotensin and equipotent with the opioid peptide dynorphin. The histamine release is clearly temperature-dependent, with no release occurring at 0 or 45 °C and with an optimum around 37 °C. The histamine release is significantly reduced in the absence of extracellular calcium.
  • In Vivo
    Kinetensin also induces a dose-dependent increase in vascular permeability when injected intradermally into rats.
  • Synonyms
    Kinetensin (human)
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Neurotensin Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    103131-69-7
  • Formula Weight
    1172.38
  • Molecular Formula
    C56H85N17O11
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (85.30 mM)
  • SMILES
    ——
  • Chemical Name
    Sequence:Ile-Ala-Arg-Arg-His-Pro-Tyr-Phe-Leu

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Mogard MH, et al. The amino acid sequence of kinetensin, a novel peptide isolated from pepsin-treated human plasma: homology with human serum albumin, neurotensin and angiotensin. Biochem Biophys Res Commun. 1986 May 14;136(3):983-8.
molnova catalog
related products
  • AVP-13358

    AVP-13358 is a CD23 antagonist (immunoglobulin ε-Fc receptor antagonist), an immunoglobulin E inhibitor.

  • AP39 Free base

    AP39 free base is a mitochondrial-targeted H(2)S donor that can improve the survival rate of porcine islets in culture.

  • Glycerol Tridecanoat...

    Glycerol Tridecanoate is also known as triacylglycerols or triacylglycerides. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins which deliver the fatty acids to and from fat cells among other functions. Various tissues can release free fatty acids and take them up as a source of energy.